Latterell Venture Partners

Bob Curry

Bob has 28 years of healthcare venture capital investing experience including active involvement with 38 start-up or early stage companies, of which 32 achieved an IPO or successful merger. Prior to his VC activities, Bob started two companies of his own, one of which was a diagnostics lab and the other was a diagnostic product company. Bob also held an academic professorship at the University of Delaware, as well as being the Director of Technology at Becton Dickinson.

Prior to joining LVP, Bob was a partner at Alliance Technology Ventures where he invested exclusively in healthcare ventures. Before ATV he was the original healthcare partner at the Sprout Group (the venture affiliate of Donaldson, Lufkin & Jenrette), and prior to Sprout he was the President of Merrill Lynch Venture Capital and Merrill Lynch R&D Management Inc. Successful portfolio companies include: Adeza Biomedical, Genoptix, Gen-Probe, Idec Pharmaceuticals, Idexx, Ligand Pharmaceuticals, Pathology Partners, Prometheus, Regeneron, and Tripath Imaging, among others.

Bob holds a Ph.D. and an M.S. in chemistry from Purdue University where he was a Smith Kline Fellow, and he received his B.S. in physics from the University of Illinois at Urbana where he was a James Scholar. He also served for many years as the Board Chair at the Keck Graduate Institute of Applied Life Sciences at the Claremont Colleges.

Copyright © 2016 by Latterell Venture Partners

LVP is Registered in the US Patent and Trademark Office